Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Flavia Sunzini, Arianna D’Antonio, Mauro Fatica, Paola Triggianese, Paola Conigliaro, Elisabetta Greco, Alberto Bergamini & Maria Sole Chimenti. (2022) What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?. Expert Opinion on Biological Therapy 22:12, pages 1545-1559.
Read now
Read now
Articles from other publishers (2)
Sherry Rohekar, Aisha Vadhariya, Sarah Ross, William Malatestinic, Boris Janos, Nicola Massey, Megan Hughes, Sarah Weatherby, Julie Birt & Anthony Sebba. (2024)
Real‐World
Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States
. ACR Open Rheumatology.
Crossref
Crossref
Beatriz Joven, Concepción Fito Manteca, Esteban Rubio, Enrique Raya, Alba Pérez, Raquel Hernández, Sara Manrique, Mercedes Núñez, Silvia Díaz-Cerezo, Sebastián Moyano, Alessandra Lacetera & Rosario García-Vicuña. (2023) Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study. Advances in Therapy 40:12, pages 5415-5431.
Crossref
Crossref